These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26714580)

  • 1. The mucosa-kidney axis in IgA nephropathy.
    Floege J; Feehally J
    Nat Rev Nephrol; 2016 Mar; 12(3):147-56. PubMed ID: 26714580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary IgA nephropathy.
    Pouria S; Barratt J
    Semin Nephrol; 2008 Jan; 28(1):27-37. PubMed ID: 18222344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S; Kimura H; Gejyo F
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gluten sensitivity in patients with IgA nephropathy.
    Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
    Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
    Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.
    He JW; Zhou XJ; Lv JC; Zhang H
    Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of the mucosa-bone marrow axis in IgA nephropathy with animal models.
    Suzuki Y; Suzuki H; Sato D; Kajiyama T; Okazaki K; Hashimoto A; Kihara M; Yamaji K; Satake K; Nakata J; Aizawa M; Novak J; Tomino Y
    Adv Otorhinolaryngol; 2011; 72():64-7. PubMed ID: 21865692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenetic potential of environmental antigens in IgA nephropathy.
    Coppo R
    Am J Kidney Dis; 1988 Nov; 12(5):420-4. PubMed ID: 3055968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosal immune system and IgA nephropathy.
    Gesualdo L; Di Leo V; Coppo R
    Semin Immunopathol; 2021 Oct; 43(5):657-668. PubMed ID: 34642783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.
    Coppo R
    Pediatr Nephrol; 2018 Jan; 33(1):53-61. PubMed ID: 28389744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy.
    Rantala I; Collin P; Holm K; Kainulainen H; Mustonen J; Mäki M
    Kidney Int; 1999 Jun; 55(6):2274-80. PubMed ID: 10354275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study of immunoglobulin A nephropathy: From research to clinical application.
    Li M; Yu X
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():26-31. PubMed ID: 30298665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production?
    Liu Y; Liu H; Peng Y; Liu F
    Ren Fail; 2014 Jul; 36(6):970-3. PubMed ID: 24828398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
    Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
    Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome.
    Harabuchi Y; Takahara M
    Immun Inflamm Dis; 2019 Jun; 7(2):86-93. PubMed ID: 30957421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping novel immunogenic epitopes in IgA nephropathy.
    Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.